BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38455766)

  • 1. Circulating serum miR-362-3p and miR-6721-5p as potential biomarkers for classification patients with adult-type diffuse glioma.
    Niemira M; Bielska A; Chwialkowska K; Raczkowska J; Skwarska A; Erol A; Zeller A; Sokolowska G; Toczydlowski D; Sidorkiewicz I; Mariak Z; Reszec J; Lyson T; Moniuszko M; Kretowski A
    Front Mol Biosci; 2024; 11():1368372. PubMed ID: 38455766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
    J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a miRNA-mRNA regulatory network for post-stroke depression: a machine-learning approach.
    Qiu H; Shen L; Shen Y; Mao Y
    Front Neurol; 2023; 14():1096911. PubMed ID: 37528851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancer.
    Niemira M; Erol A; Bielska A; Zeller A; Skwarska A; Chwialkowska K; Kuzmicki M; Szamatowicz J; Reszec J; Knapp P; Moniuszko M; Kretowski A
    Sci Rep; 2023 Nov; 13(1):19287. PubMed ID: 37935712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas.
    Wu J; Al-Zahrani A; Beylerli O; Sufianov R; Talybov R; Meshcheryakova S; Sufianova G; Gareev I; Sufianov A
    Front Oncol; 2022; 12():898537. PubMed ID: 35646622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-330-3p and miR-485-5p as biomarkers for glioblastoma: An integrated bioinformatics and experimental study.
    Rahmati Y; Alivand M; Mollanoori H
    Comput Biol Chem; 2021 Jun; 92():107458. PubMed ID: 33761401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep sequencing of circulating exosomal microRNA allows non-invasive glioblastoma diagnosis.
    Ebrahimkhani S; Vafaee F; Hallal S; Wei H; Lee MYT; Young PE; Satgunaseelan L; Beadnall H; Barnett MH; Shivalingam B; Suter CM; Buckland ME; Kaufman KL
    NPJ Precis Oncol; 2018; 2():28. PubMed ID: 30564636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on identification of a three-microRNA panel in serum for diagnosing neonatal early onset sepsis.
    Zhao Y; Lu C; Zhu R; Hu X
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2280527. PubMed ID: 37968923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Throughput Sequencing-Based Identification of Serum Exosomal Differential miRNAs in High-Grade Glioma and Intracranial Lymphoma.
    Wang S; Xu Z; Zhang C; Yu R; Jiang J; Wang C; Qu C
    Biomed Res Int; 2020; 2020():2102645. PubMed ID: 33083454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1.
    Wang L; Liu Y; Yu Z; Gong J; Deng Z; Ren N; Zhong Z; Cai H; Tang Z; Cheng H; Chen S; He Z
    J Transl Med; 2021 May; 19(1):213. PubMed ID: 34001135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer.
    Zhang K; Wang YY; Xu Y; Zhang L; Zhu J; Si PC; Wang YW; Ma R
    Pathol Res Pract; 2021 Jun; 222():153458. PubMed ID: 33962174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating exosomal miRNAs as novel biomarkers for acute aortic dissection: A diagnostic accuracy study.
    Zhang D; Zhao X; Wang B; Liu X; Aizezi A; Ma X
    Medicine (Baltimore); 2023 Jul; 102(30):e34474. PubMed ID: 37505131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic, grading and prognostic role of a restricted miRNAs signature in primary and metastatic brain tumours. Discussion on their therapeutic perspectives.
    Nikolova E; Georgiev C; Laleva L; Milev M; Spiriev T; Stoyanov S; Taseva-Mineva T; Mitev V; Todorova A
    Mol Genet Genomics; 2022 Mar; 297(2):357-371. PubMed ID: 35064290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis.
    Xue WX; Zhang MY; Rui Li ; Liu X; Yin YH; Qu YQ
    Biomed Res Int; 2020; 2020():9601876. PubMed ID: 32724822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
    Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
    Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test.
    Li R; Xia Y; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Li M; Lin Y; Dong J; Ji L; Lai Y
    Transl Cancer Res; 2022 May; 11(5):1005-1016. PubMed ID: 35706801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
    Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
    Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer.
    Fan X; Zou X; Liu C; Cheng W; Zhang S; Geng X; Zhu W
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34076696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-16-5p is frequently down-regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy.
    Krell A; Wolter M; Stojcheva N; Hertler C; Liesenberg F; Zapatka M; Weller M; Malzkorn B; Reifenberger G
    Neuropathol Appl Neurobiol; 2019 Aug; 45(5):441-458. PubMed ID: 30548945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Serum miRNAs as Effective Diagnostic Biomarkers for Distinguishing Primary Central Nervous System Lymphoma from Glioma.
    Si PP; Zhou XH; Qu ZZ
    J Immunol Res; 2022; 2022():5052609. PubMed ID: 35497882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.